Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Diabetes: FDA puts highest risk label on Abbott’s blood glucose test strip recall
FDA regulators issues the highest-risk Class I label over concerns that erroneous test results produced by some Abbott blood glucose testing strips may harm patients.
2. Bard can’t keep internal memos out of pelvic mesh trial
C.R. Bard won’t be allowed to exclude internal memos about its recalled Avaulta pelvic mesh from a bellwether product liability trial, a federal judge ruled last week.
1. GE Healthcare offers $1.06B for trio of Thermo Fisher lifesciences units
GE Healthcare offers $1.06 billion to acquire the cell culture, gene modulation and magnetic beads businesses of Thermo Fisher Scientific, which is eying a mega-deal of its own.
